News about "While the number of deals was lower than the 12-mo"

Biopharma and Healthcare Manufacturing Drive USD 18.3 Billion in Deals in July 2025 Despite Drop in Volume

Biopharma and Healthcare Manufacturing Drive USD 18.3 Billion in Deals in July 2025 Despite Drop in Volume

While the number of deals was lower than the 12-month average of 95, the total deal value was significantly higher than the USD 13.2 billion average recorded between July 2024 and June 2025.

While The Number Of Deals Was Lower Than The 12-mo | 08/08/2025 | By Darshana 209


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members